期刊文献+

基于TCGA和ICGC数据库的肝细胞癌血管生成相关基因预后风险模型的建立

Establishment of a prognostic risk model for hepatocellular carcinoma angiogenesis based on TCGA and ICGC database
下载PDF
导出
摘要 目的:基于血管生成相关基因(Angiogenesis-related genes,ARGs)构建肝细胞癌(Hepatocellular carcinoma,HCC)患者预后风险模型,为肝癌的预后和治疗提供策略。方法:从TGGA数据库下载50例正常肝组织和374例HCC组织样本的表达谱和对应的临床信息,同时从ICGC数据库下载48例正常肝组织和294例HCC组织样本的表达谱和临床信息。从Harmonizome和MSigDB数据库共收集到225个ARGs作为基因集,DESeq2包筛选出差异表达基因(Differential expression genes,DEGs)。利用单因素Cox回归分析确定对患者生存预后相关基因构建预后风险模型并应用ROC曲线评估模型对于HCC患者预后的预测能力。结果:从Harmonizome和MSigDB数据库的相关通路中共筛选出225个ARGs,其中137个ARGs在TCGA-LIHC和ICGC-LIHC数据集中均表达。对2个数据集ARGs进行单因素Cox回归分析,得到11个预后相关基因(F7、NARS、EMCN、SLCO^(2)A1、EGF、ITGAV、KDR、PTPRB、SPP1、ANGPT2、BIRC5),高风险组患者的OS明显低于低风险组(P<0.05)。在TCGA-LIHC数据集和ICGC-LIHC数据集中,11个预后相关基因均与肝癌患者的预后相关(P<0.05),其中ANGPT2、BIRC5、EGF、ITGAV、SPP1和NARS高表达者预后更差,SLCO^(2)A1、EMCN、F7、KDR和PTPRB低表达者预后更差。在GSE116174中,4个预后相关基因与肝癌患者预后相关(P<0.05),其中ANGPT2、BIRC5和SPP1高表达者预后更差,SLCO^(2)A1低表达者预后更差。在GSE14520中,7个预后相关基因与肝癌患者预后相关(P<0.05),其中ANGPT2、EGF和SPP1高表达者预后更差,F7、SLCO^(2)A1、KDR和PTPRB低表达者预后更差。结论:基于TCGA和ICGC数据库筛选到11个预后相关基因,可作为肝癌研究的潜在靶点。 Objective:To construct a prognostic risk model for patients with HCC based on angiogenesis-related genes(ARGs),aiming to provide strategies for prognosis and treatment of HCC.Methods:We downloaded expression profiles and corresponding clinical information of 50 normal samples and 374 HCC samples from the TGGA database,and expression profiles and clinical information of 48 normal liver tissues and 294 HCC tissues from the ICGC database.A total of 225 ARGs were collected from the Harmonizome and MSigDB databases as a gene set and screened for differentially expressed genes(DEGs)using the DESeq2 package.Univariate Cox regression analysis were used to determine the genes significantly associated with patient survival prognosis,and finally a prognostic risk model was constructed.The model's ability to predict the prognosis of HCC patients was evaluated using ROC curves.Results:A total of 225 ARGs were screened from Harmonizome and MSigDB databases,of which 137 ARGs were significantly differential expressed in both the TCGA-LIHC and ICGC-LIHC datasets.Univariate Cox regression analysis of 82 upregulated ARGs and 55 downregulated ARGs in both datasets identified 11 prognostic genes(F7,NARS,EMCN,SLCO^(2)A1,EGF,ITGAV,KDR,PTPRB,SPP1,ANGPT2,BIRC5).The OS of high risk group was significantly lower than that of low risk group(P<0.05).In the TCGA-LIHC dataset and ICGC-LIHC dataset,11 prognostic related genes were correlated with the prognosis of HCC patients(P<0.05),among which those with high expression of ANGPT2,BIRC5,EGF,ITGAV,SPP1and NARShad worse prognosis.Those with low expression of SLCO^(2)A1,EMCN,F7,KDR and PTPRB had worse prognosis.In GSE116174,four prognostic related genes were associated with the prognosis of liver cancer patients(P<0.05),among which those with high expression of ANGPT2,BIRC5 and SPP1 had worse prognosis,and those with low expression of SLCO^(2)A1had worse prognosis.In GSE14520,7 prognostic genes were associated with the prognosis of liver cancer patients(P<0.05),among which those with high expression of ANGPT2,EGFand SPP1had worse prognosis,and those with low expression of F7,SLCO^(2)A1,KDR and PTPRB had worse prognosis.Conclusion:This study established a prognostic model comprising 11 prognostic genes based on the TCGA and ICGC databases,serving as potential targets for liver cancer research.
作者 张飞亚 刘子宣 程旭 张鹏 ZHANG Fei-ya;LIU Zi-xuan;CHENG Xu;ZHANG Peng(Gannan Innovation and Translational Medicine Research Institute,Gannan Medical University,Ganzhou,Jiangxi 341000)
出处 《赣南医学院学报》 2024年第6期556-564,共9页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 肝细胞癌 基因 血管生成 预测模型 风险评分 Hepatocellular carcinoma Genes Angiogenesis Prediction model Risk score
  • 相关文献

参考文献3

二级参考文献30

  • 1Shu-Guang Zheng,Hui-Xiong Xu,Lin-Na Liu.Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound[J].World Journal of Radiology,2014,6(1):7-14. 被引量:22
  • 2Caterina Pozzan,Romilda Cardin,Marika Piciocchi,Nora Cazzagon,Gemma Maddalo,Veronica Vanin,Anna Giacomin,Patrizia Pontisso,Umberto Cillo,Fabio Farinati.Diagnostic and prognostic role of SCCA ‐ IgM serum levels in hepatocellular carcinoma ( HCC )[J]. J Gastroenterol Hepatol . 2014 (8)
  • 3Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 4Zhong-Bo Han,Hong-Yuan Chen,Jun-Wei Fan,Jun-Yi Wu,Hua-Mei Tang,Zhi-Hai Peng.Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation[J].Journal of Cancer Research and Clinical Oncology.2012(1)
  • 5Sean F. Altekruse,Katherine A. McGlynn,Marsha E. Reichm.Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005. Japanese Journal of Clinical Oncology . 2009
  • 6Gupta Samir,Bent Stephen,Kohlwes Jeffrey.Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Annals of Internal Medicine . 2003
  • 7Patrick Reichl,Meng Fang,Patrick Starlinger,Katharina Staufer,Rudolf Nenutil,Petr Muller,Kristina Greplova,Dalibor Valik,Steven Dooley,Christine Brostjan,Thomas Gruenberger,Jiayun Shen,Kwan Man,Michael Trauner,Jun Yu,Chun Fang Gao,Wolfgang Mikulits.Multicenter analysis of soluble A xl reveals diagnostic value for very early stage hepatocellular carcinoma[J]. Int. J. Cancer . 2015 (2)
  • 8Athina Chounta,Christofer Ellinas,Vassiliki Tzanetakou,Fani Pliarhopoulou,Virginia Mplani,Angelos Oikonomou,Kostantinos Leventogiannis,Evangelos J. Giamarellos‐Bourboulis.Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma[J]. Liver Int . 2015 (2)
  • 9Karim Y. A. Shaheen,Abeer I. Abdel-Mageed,Eslam Safwat,Ashraf M. AlBreedy,Shigeru Marubashi.The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma[J]. International Journal of Hepatology . 2015
  • 10Nicolas Poté,Fran?ois Cauchy,Miguel Albuquerque,Hélène Voitot,Jacques Belghiti,Laurent Castera,Hervé Puy,Pierre Bedossa,Valérie Paradis.Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J]. Journal of Hepatology . 2014

共引文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部